Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Novo Nordisk 12.087, Pfizer 15.034.
Novo Nordisk vs Pfizer: Revenue Comparison
Novo Nordisk (NVO) and Pfizer (PFE) are peers in GLP-1. Novo Nordisk reported revenue of $12.1B as of Q2 2026, compared with $15.0B for Pfizer. Pfizer leads on revenue.
Novo Nordisk's gross margin is 78.2% versus 72.8% for Pfizer. Novo Nordisk's net margin is 26.7% versus -1.6% for Pfizer.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Novo Nordisk, Pfizer.| Metric | Novo Nordisk | Pfizer |
|---|---|---|
| Market Cap | - | - |
| Revenue | $12.09B | $15.03B |
| Cost of Revenue | $2.63B | $4.09B |
| Gross Profit | $9.45B | $10.94B |
| Operating Income | $4.17B | $4.71B |
| Net Income | $3.23B | $-246.00M |
| R&D Expense | $2.74B | $2.81B |
| Earnings Per Share | $0.73 | -$0.04 |
| Gross Margin | 78.2% | 72.8% |
| Operating Margin | 34.5% | 31.3% |
| Net Profit Margin | 26.7% | -1.6% |
| Free Cash Flow | $6.53B | $302.00M |
| Cumulative Free Cash Flow | $107.39B | $356.70B |
| Operating Cash Flow | $8.50B | $835.00M |
| Cash & Equivalents | $6.85B | $976.00M |